Freund John Gordon

Freund John Gordon is listed in filings as Director at Collegium Pharmaceutical, Inc.. This profile follows SEC Form 4 activity through May 20, 2026, including sale activity. Recent filings connect the profile to Collegium Pharmaceutical, Inc. (COLL) and SI-BONE, Inc. (SIBN). The current snapshot covers public activity from Jun 27, 2024 to May 20, 2026. Reported amounts are shown as $681 to $142.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.